Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Performance-Enhancing Drugs at Work: An Ethics Poll
- Performance-Enhancing Drugs at Work: An Ethics PollNot an either/orThe use of synthetic drugs to enhance performance is an issue to me, not so much because it helps an individual perform better, but because of the long-term effects on the brain and body. The extended use of steroids has been proven...
- Discussion threads 2008-05-13
Additional Resources
- About generic drugs.(U.S. Food and Drug Administration information)(Brief Article)
- A generic drug is one that is identical to a brand-name drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Although generic drugs are chemically identical to their branded counterpar A generic drug is one that is identical to a...
- Research articles 2003-04-14
- Would You Take Drugs to Boost Your Productivity? A Pill-Popping Poll
- In Better Management Through Drug Abuse, I raise the specter of top management requiring people to take certain kinds of mind-altering drugs. The arguments in favor of using such drugs, as put forth by academics, seem absurdly weak to me. And yet there are clear reasons to consider such drugs,...
- Blog posts 2009-01-09
- With New CV Drugs, Gilead Tests Its Commitment to Efficiency
- Gilead received some good news today with the results of a positive phase 3 study of its new high-blood pressure drug, darusentan. Combined with Gilead's purchase of CV Therapeutics to gain the chronic angina drug Ranexa, this marks a new push into the cardio-vascular area for a...
- Blog posts 2009-04-03
- Regulatory compliance is a good business practice; market leaders use government, customer mandates to fine-tune business processes.(Business Performance)
- Cambrex Corp., East Rutherford, N.J., has a very interesting business model. While its mainstay is developing technology that helps pharmaceutical companies discover and test new drugs, sometimes it takes over the process of manufacturing the drugs Cambrex Corp., East Rutherford, N.J., has a very...
- Research articles 2005-08-01
- Generic Drugs: Industry Snapshot
- Mike Havrilla submits:Global Generic Drug Industry: Benchmark Comps Global Generic Drug Industry: Top 5 Companies by Market Cap Global Generic Drugs: Top 5 Companies by Stock Performance The accompanying tables provide a snapshot of my 38-company Global Generic Drug Index, which is rapidly consolidating amidst a flurry of recent M&A activity --...
- External links 2008-08-15
- Just say yes to pro sports drugs?
- NEW YORK, Dec. 2, 2005 -- The commissioners of Major League Baseball and the National Football League today announced a new "Just Say Yes" policy on drugs. From now on, they said, players would no longer be tested for drugs. Instead, they would be free to use any drug...
- Research articles 2003-12-02
- Outrage after doping uncovered at Chinese sports school
- BEIJING AFP — Teachers at an athletics school in China have been caught injecting teenagers with performance-boosting drugs in a scandal that has caused fury in Beijing ahead of the 2008 Olympics, state media have said. China's sports administration has accused the school of "collective doping" after the teachers were...
- Research articles 2006-08-24
- Competing On Analytics: How Pharmaceutical Companies Use Analytics To Achieve High Performance
- In the pharmaceutical industry, business is anything but smooth sailing. Most pharmaceutical companies are under enormous pressure to discover and develop new drugs faster and more frequently as patents on existing drugs expire and generics are aggressively coming to market. But filling their development pipelines with innovative products from their...
- White papers 2007-07-01
- Can "Pay for Performance" Increase Utilization by the Poor and Improve the Quality of Health Services?
- Increased world focus on improving health outcomes, as evidenced by initiatives such as the Global Fund, GAVI, PEPFAR, and the global commitment to meet the Millennium Development Goals, is revealing that money, buildings, numbers of health workers and drugs only move countries part of the way toward adequate utilization of...
- White papers 2006-02-07
- Improving Logistics Performance in Danish Pharmaceutical Supply Chains
- Based on literature review and case studies, this article discusses how new types of delivery systems can improve logistics performance in pharmaceutical supply chains. Examples of Danish pharmaceutical companies are provided and benefits are described from a supply chain management point of view. The goal of logistics is to satisfy...
- White papers 2003-10-10
- FDA Accelerates Its Approval of New Drugs.(Brief Article)
- THE FOOD AND DRUG Administration's Center for Drug Evaluation and Research reviewed 199 new drug applications in 1998 and approved 90 of them, according to an FDA performance report. The average review time by the FDA department in 1998 was 12 ...
- Research articles 1999-02-15
- New Drugs Boost Profits at Johnson & Johnson in Fourth Quarter.(Originated from The Star-Ledger, Newark, N.J.)
- Jan. 22--Buoyed by new products, Johnson & Johnson continued its strong financial performance by reporting yesterday that revenue and earnings rose substantially in its fourth quarter. Jan. 22--Buoyed by new products, Johnson & Johnson continued its strong financial performance by reporting...
- Research articles 1997-01-22
- Powering High Performance, Wherever You Are
- Global Pharmaceutical Company strives for high performance by leveraging Accenture's outsourcing expertise across the globe. Patents on several of this company's best-selling products were expiring, opening those drugs to generic competition and threatening company profits. Facing increased competition, the company launched an ambitious program to dramatically cut costs and reduce...
- White papers 2007-10-18
- Daiichi Sankyo Company Limited: Business Transformation Maintains Momentum Towards High Performance
- Daiichi Sankyo Company Limited, established in 2005 after the merger of two leading century-old Japanese pharmaceutical companies, is a global pharmaceutical innovator, continuously generating innovative drugs that enrich the quality of life for patients around the world. To maintain its momentum toward high performance, Daiichi Sankyo knew that it needed...
- White papers 2009-08-27
- Perceived Barriers for Treatment of Chronic Heart Failure in General Practice; Are They Affecting Performance?
- The aim of this study is to determine to what extent barriers perceived by general practitioners GPs for prescribing angiotensin-converting enzyme inhibitors (ACE-I) in chronic heart failure CHF patients are related to under use and under dosing of these drugs in actual practice. The study depicts that the variation between...
- White papers 2005-05-03
- Drugs-cheat Millar set to lose world title, sacked by Cofidis
- PARIS AFP ? David Millar, who is set to be stripped of his world time-trial title, confessed to police that he had taken the banned performance enhancer EPO. On a bleak day for Britain's top cyclist, Millar emerged from a courtroom in the Paris suburb of Nanterre after a...
- Research articles 2004-07-20
- PRESCRIPTION DRUGS TAKE BIGGER BITE OUT OF COMP
- Workers compensation continues to be a problem line even as improvements are experienced in many other lines of business. As Dennis Mealy, FCAS, MAAA, chief actuary, National Council on Compensation Insurance NCCI, noted in his "state of the line" report at the NCCI annual meeting, "compared to most other lines...
- Research articles 2004-12-01
- Belgian cycling great to stand trial for drugs scandal
- COURTRAI, Belgium AFP — Belgium's former world champion cyclist Johan Museeuw and 10 others implicated in a doping scandal are to face trial, prosecutors said. Museeuw, the 1996 world road race champion, stands accused of possessing the banned blood booster EPO erythropoeitin and two other illegal performance enhancers. ...
- Research articles 2006-03-17
- 'Belgian pot' dope peddlars face jail time
- BORDEAUX, France AFP — A French prosecutor demanded hefty jail terms against the key figures of a network accused of hooking amateur cyclists on performance-boosting drugs. Belgian ex-trainer Freddy Sergant faces a four-year prison sentence and ex-riders Laurent and Fabien Roux face 30-month partly suspended terms for allegedly dealing...
- Research articles 2006-06-21
- << Previous
- page 1 of 1
- Next >>
